Company: RGNX
Filing Date: 2025-03-13
Form Type: 10-K
Source: 0000950170-25-038770
Chunk: 278

Company: REGENXBIO Inc.
Filing Date: 2025-03-13
Form: 10-K
Item: Item 1B
Chunk 278
---
         
        $
        34.73

        Outstanding at December 31, 2024

        9,994

        $
        29.48

        5.9

        $
        240

        Exercisable at December 31, 2024

        6,837

        $
        34.20

        4.8

        $
        240

        Vested and expected to vest at December 31, 2024

        9,994

        $
        29.48

        5.9

        $
        240

       (a)The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the fair value of the common stock for the options that were in the money at the dates reported.

120

The weighted-average grant date fair value per share of options granted during the years ended December 31, 2024, 2023 and 2022 was $9.98, $13.66 and $19.43, respectively. During the years ended December 31, 2024, 2023 and 2022, the total number of stock options exercised was 290,753, 222,935 and 331,912, respectively, resulting in total proceeds of $1.5 million, $1.5 million and $2.8 million, respectively. The total intrinsic value of options exercised during the years ended December 31, 2024, 2023 and 2022 was $3.1 million, $2.9 million and $6.9 million, respectively. The fair values of options granted were estimated at each grant date using the Black-Scholes valuation model with the following weighted-average assumptions:  

        Years Ended December 31,

        2024

        2023

        2022

        Expected volatility

        64
        %

        65
        %

        66
        %

        Expected term (years)

        6.0

        6.0

        6.0

        Risk-free interest rate

        4.0
        %

        3.9
        %

        1.7
        %

        Expected dividend yield

        0.0
        %

        0.0
        %

        0.0
        %
       
       Restricted Stock UnitsThe following table summarizes restricted stock unit activity under the 2015 Plan